3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Glaucoma, Suspect

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Glaucoma, Suspect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, X; Dong, L; Hu, Y; Zhou, L	1

Other Studies

1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Glaucoma, Suspect

Article	Year
P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model. Molecular medicine reports, 2018, Volume: 17, Issue:2 Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase 1; Chronic Disease; Disease Models, Animal; Gene Expression; Microglia; Ocular Hypertension; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Retina; Retinal Ganglion Cells	2018

Article

Year

P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model.

Molecular medicine reports, 2018, Volume: 17, Issue:2

Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase 1; Chronic Disease; Disease Models, Animal; Gene Expression; Microglia; Ocular Hypertension; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Retina; Retinal Ganglion Cells

2018